HEADER HYDROLASE 28-MAY-97 1TIP TITLE THE BISPHOSPHATASE DOMAIN OF THE BIFUNCTIONAL RAT LIVER 6- TITLE 2 PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: PHOSPHOENZYME INTERMEDIATE OF FRU-2,6-BISPHOSPHATASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: D-FRUCTOSE-2,6-BISPHOSPHATE 2-PHOSPHOHYDROLASE; COMPND 5 EC: 3.1.3.46; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 ORGAN: LIVER; SOURCE 6 GENE: A CODING REGION WHICH COVERS; SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: DL41 DE3; SOURCE 10 EXPRESSION_SYSTEM_PLASMID: PET3A; SOURCE 11 EXPRESSION_SYSTEM_GENE: A CODING REGION WHICH COVERS FRUCTOSE-2,6- SOURCE 12 BISPHOSPHATASE DOMAIN (RESIDUES 251 - 440) OF THE RAT LIVER 6-PF-2- SOURCE 13 K/FRU-2,6-P2ASE (RESIDUES 1 - 470) KEYWDS MULTIFUNCTIONAL ENZYME, TRANSFERASE, KINASE, ATP-BINDING, KEYWDS 2 PHOSPHORYLATION, ALTERNATIVE SPLICING, MULTIGENE FAMILY, HYDROLASE EXPDTA X-RAY DIFFRACTION AUTHOR Y.-H.LEE,T.W.OLSON,C.M.OGATA,D.G.LEVITT,L.J.BANASZAK,A.J.LANGE REVDAT 3 29-JUL-20 1TIP 1 COMPND REMARK SEQADV HETNAM REVDAT 3 2 1 LINK SITE REVDAT 2 24-FEB-09 1TIP 1 VERSN REVDAT 1 28-JAN-98 1TIP 0 JRNL AUTH Y.H.LEE,T.W.OLSON,C.M.OGATA,D.G.LEVITT,L.J.BANASZAK, JRNL AUTH 2 A.J.LANGE JRNL TITL CRYSTAL STRUCTURE OF A TRAPPED PHOSPHOENZYME DURING A JRNL TITL 2 CATALYTIC REACTION. JRNL REF NAT.STRUCT.BIOL. V. 4 615 1997 JRNL REFN ISSN 1072-8368 JRNL PMID 9253407 JRNL DOI 10.1038/NSB0897-615 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH S.J.PILKIS,T.H.CLAUS,I.J.KURLAND,A.J.LANGE REMARK 1 TITL 6-PHOSPHOFRUCTO-2-KINASE/FRUCTOSE-2,6-BISPHOSPHATASE: A REMARK 1 TITL 2 METABOLIC SIGNALING ENZYME REMARK 1 REF ANNU.REV.BIOCHEM. V. 64 799 1995 REMARK 1 REFN ISSN 0066-4154 REMARK 1 REFERENCE 2 REMARK 1 AUTH Y.H.LEE,K.LIN,D.OKAR,N.L.ALFANO,R.SARMA,J.W.PFLUGRATH, REMARK 1 AUTH 2 S.J.PILKIS REMARK 1 TITL PRELIMINARY X-RAY ANALYSIS OF A TRUNCATED FORM OF REMARK 1 TITL 2 RECOMBINANT FRUCTOSE-2,6-BISPHOSPHATASE REMARK 1 REF J.MOL.BIOL. V. 235 1147 1994 REMARK 1 REFN ISSN 0022-2836 REMARK 2 REMARK 2 RESOLUTION. 2.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : X-PLOR REMARK 3 AUTHORS : BRUNGER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.20 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : NULL REMARK 3 DATA CUTOFF LOW (ABS(F)) : NULL REMARK 3 COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 NUMBER OF REFLECTIONS : 20142 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : NULL REMARK 3 FREE R VALUE TEST SET SELECTION : NULL REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.286 REMARK 3 FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF FREE R VALUE : NULL REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : NULL REMARK 3 BIN RESOLUTION RANGE HIGH (A) : NULL REMARK 3 BIN RESOLUTION RANGE LOW (A) : NULL REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 REFLECTIONS IN BIN (WORKING SET) : NULL REMARK 3 BIN R VALUE (WORKING SET) : NULL REMARK 3 BIN FREE R VALUE : NULL REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : NULL REMARK 3 BIN FREE R VALUE TEST SET COUNT : NULL REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : NULL REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3118 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 32 REMARK 3 SOLVENT ATOMS : 284 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 27.94 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : NULL REMARK 3 B22 (A**2) : NULL REMARK 3 B33 (A**2) : NULL REMARK 3 B12 (A**2) : NULL REMARK 3 B13 (A**2) : NULL REMARK 3 B23 (A**2) : NULL REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.30 REMARK 3 ESD FROM SIGMAA (A) : NULL REMARK 3 LOW RESOLUTION CUTOFF (A) : NULL REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : NULL REMARK 3 ESD FROM C-V SIGMAA (A) : NULL REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.012 REMARK 3 BOND ANGLES (DEGREES) : 1.597 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 23.46 REMARK 3 IMPROPER ANGLES (DEGREES) : 1.561 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN BOND (A**2) : NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE (A**2) : NULL ; NULL REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : NULL REMARK 3 TOPOLOGY FILE 1 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 1TIP COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY BNL. REMARK 100 THE DEPOSITION ID IS D_1000176704. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-MAY-97 REMARK 200 TEMPERATURE (KELVIN) : 95 REMARK 200 PH : NULL REMARK 200 NUMBER OF CRYSTALS USED : NULL REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.02 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : FUJI REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : NULL REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 20142 REMARK 200 RESOLUTION RANGE HIGH (A) : NULL REMARK 200 RESOLUTION RANGE LOW (A) : NULL REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 78.3 REMARK 200 DATA REDUNDANCY : 8.900 REMARK 200 R MERGE (I) : 0.05200 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: NULL REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: X-PLOR REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NUMBER OF CRYSTALS 1. REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.77 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: A CATALYTIC PHOSPHOSENZYME REMARK 280 INTERMEDIATE STATE OF THE BISPHOSPHATASE WAS PREPARED BY SOAKING REMARK 280 OF THE NATIVE CRYSTAL OF THE PROTEIN AND TRAPPED USING THE REMARK 280 CRYOGENIC DEVICE. A 2.2 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF REMARK 280 THE INTERMEDIATE WAS DETERMINED. A PHOSPHORYLATED CATALYTIC REMARK 280 HISTIDINE WAS VISUALIZED ALONG WITH THE FIRST PRODUCT, FRUCTOSE- REMARK 280 6 - PHOSPHATE, AND THE CATALYTIC WATER, SHOWING THE REMARK 280 COMPREHENSIVE GEOMETRY OF A TRIGONAL BI-PYRAMIDAL STRUCTURE. REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 28.26000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS REMARK 500 REMARK 500 THE FOLLOWING ATOMS THAT ARE RELATED BY CRYSTALLOGRAPHIC REMARK 500 SYMMETRY ARE IN CLOSE CONTACT. AN ATOM LOCATED WITHIN 0.15 REMARK 500 ANGSTROMS OF A SYMMETRY RELATED ATOM IS ASSUMED TO BE ON A REMARK 500 SPECIAL POSITION AND IS, THEREFORE, LISTED IN REMARK 375 REMARK 500 INSTEAD OF REMARK 500. ATOMS WITH NON-BLANK ALTERNATE REMARK 500 LOCATION INDICATORS ARE NOT INCLUDED IN THE CALCULATIONS. REMARK 500 REMARK 500 DISTANCE CUTOFF: REMARK 500 2.2 ANGSTROMS FOR CONTACTS NOT INVOLVING HYDROGEN ATOMS REMARK 500 1.6 ANGSTROMS FOR CONTACTS INVOLVING HYDROGEN ATOMS REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI SSYMOP DISTANCE REMARK 500 OH TYR A 180 OE2 GLU B 91 2646 1.73 REMARK 500 CG GLU B 98 O HOH A 763 2646 1.97 REMARK 500 O HOH A 609 O HOH A 648 2656 1.97 REMARK 500 O HOH A 574 O HOH B 596 1655 2.02 REMARK 500 CA ARG A 124 O HOH B 523 1655 2.06 REMARK 500 O GLU B 86 O HOH A 593 2656 2.10 REMARK 500 NH2 ARG A 183 NH1 ARG B 19 2646 2.18 REMARK 500 O HOH A 617 O HOH A 644 2746 2.19 REMARK 500 CZ ARG A 183 NH1 ARG B 19 2646 2.19 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 134 34.46 -91.03 REMARK 500 GLU A 136 -102.46 -100.16 REMARK 500 CYS A 142 -137.28 -128.53 REMARK 500 ASP A 156 75.42 44.13 REMARK 500 PRO A 163 -4.34 -59.99 REMARK 500 SER B 54 -168.27 -107.67 REMARK 500 GLU B 136 -125.78 -99.84 REMARK 500 CYS B 142 -135.76 -131.37 REMARK 500 ASP B 156 73.59 49.73 REMARK 500 VAL B 178 -156.98 -127.28 REMARK 500 REMARK 500 REMARK: NULL REMARK 600 REMARK 600 HETEROGEN REMARK 600 REMARK 600 A COMPETITIVE INHIBITOR, PHOSPHATE, WAS USED FOR THE REMARK 600 CRYSTALLIZATION BUFFER. THE PRESENCE OF PI IN THE PROTEIN REMARK 600 STRUCTURE WAS USED TO IDENTIFY THE ACTIVE SITE. DBREF 1TIP A 2 191 UNP P07953 F261_RAT 251 440 DBREF 1TIP B 2 191 UNP P07953 F261_RAT 251 440 SEQADV 1TIP NEP A 9 UNP P07953 HIS 258 MODIFIED RESIDUE SEQADV 1TIP NEP B 9 UNP P07953 HIS 258 MODIFIED RESIDUE SEQRES 1 A 191 MET ARG SER ILE TYR LEU CYS ARG NEP GLY GLU SER GLU SEQRES 2 A 191 LEU ASN LEU ARG GLY ARG ILE GLY GLY ASP SER GLY LEU SEQRES 3 A 191 SER ALA ARG GLY LYS GLN TYR ALA TYR ALA LEU ALA ASN SEQRES 4 A 191 PHE ILE ARG SER GLN GLY ILE SER SER LEU LYS VAL TRP SEQRES 5 A 191 THR SER HIS MET LYS ARG THR ILE GLN THR ALA GLU ALA SEQRES 6 A 191 LEU GLY VAL PRO TYR GLU GLN TRP LYS ALA LEU ASN GLU SEQRES 7 A 191 ILE ASP ALA GLY VAL CYS GLU GLU MET THR TYR GLU GLU SEQRES 8 A 191 ILE GLN GLU HIS TYR PRO GLU GLU PHE ALA LEU ARG ASP SEQRES 9 A 191 GLN ASP LYS TYR ARG TYR ARG TYR PRO LYS GLY GLU SER SEQRES 10 A 191 TYR GLU ASP LEU VAL GLN ARG LEU GLU PRO VAL ILE MET SEQRES 11 A 191 GLU LEU GLU ARG GLN GLU ASN VAL LEU VAL ILE CYS HIS SEQRES 12 A 191 GLN ALA VAL MET ARG CYS LEU LEU ALA TYR PHE LEU ASP SEQRES 13 A 191 LYS SER SER ASP GLU LEU PRO TYR LEU LYS CYS PRO LEU SEQRES 14 A 191 HIS THR VAL LEU LYS LEU THR PRO VAL ALA TYR GLY CYS SEQRES 15 A 191 ARG VAL GLU SER ILE TYR LEU ASN VAL SEQRES 1 B 191 MET ARG SER ILE TYR LEU CYS ARG NEP GLY GLU SER GLU SEQRES 2 B 191 LEU ASN LEU ARG GLY ARG ILE GLY GLY ASP SER GLY LEU SEQRES 3 B 191 SER ALA ARG GLY LYS GLN TYR ALA TYR ALA LEU ALA ASN SEQRES 4 B 191 PHE ILE ARG SER GLN GLY ILE SER SER LEU LYS VAL TRP SEQRES 5 B 191 THR SER HIS MET LYS ARG THR ILE GLN THR ALA GLU ALA SEQRES 6 B 191 LEU GLY VAL PRO TYR GLU GLN TRP LYS ALA LEU ASN GLU SEQRES 7 B 191 ILE ASP ALA GLY VAL CYS GLU GLU MET THR TYR GLU GLU SEQRES 8 B 191 ILE GLN GLU HIS TYR PRO GLU GLU PHE ALA LEU ARG ASP SEQRES 9 B 191 GLN ASP LYS TYR ARG TYR ARG TYR PRO LYS GLY GLU SER SEQRES 10 B 191 TYR GLU ASP LEU VAL GLN ARG LEU GLU PRO VAL ILE MET SEQRES 11 B 191 GLU LEU GLU ARG GLN GLU ASN VAL LEU VAL ILE CYS HIS SEQRES 12 B 191 GLN ALA VAL MET ARG CYS LEU LEU ALA TYR PHE LEU ASP SEQRES 13 B 191 LYS SER SER ASP GLU LEU PRO TYR LEU LYS CYS PRO LEU SEQRES 14 B 191 HIS THR VAL LEU LYS LEU THR PRO VAL ALA TYR GLY CYS SEQRES 15 B 191 ARG VAL GLU SER ILE TYR LEU ASN VAL MODRES 1TIP NEP A 9 HIS N1-PHOSPHONOHISTIDINE MODRES 1TIP NEP B 9 HIS N1-PHOSPHONOHISTIDINE HET NEP A 9 14 HET NEP B 9 14 HET F6P A 401 16 HET F6P B 402 16 HETNAM NEP N1-PHOSPHONOHISTIDINE HETNAM F6P 6-O-PHOSPHONO-BETA-D-FRUCTOFURANOSE FORMUL 1 NEP 2(C6 H10 N3 O5 P) FORMUL 3 F6P 2(C6 H13 O9 P) FORMUL 5 HOH *284(H2 O) HELIX 1 1 GLU A 13 LEU A 16 1 4 HELIX 2 2 ALA A 28 GLN A 44 1 17 HELIX 3 3 LYS A 57 LEU A 66 1 10 HELIX 4 4 LYS A 74 LEU A 76 5 3 HELIX 5 5 GLY A 82 CYS A 84 5 3 HELIX 6 6 TYR A 89 HIS A 95 1 7 HELIX 7 7 PRO A 97 GLN A 105 1 9 HELIX 8 8 TYR A 118 GLU A 133 1 16 HELIX 9 9 GLN A 144 PHE A 154 1 11 HELIX 10 10 SER A 159 TYR A 164 1 6 HELIX 11 11 GLU B 13 LEU B 16 1 4 HELIX 12 12 ALA B 28 GLN B 44 1 17 HELIX 13 13 LYS B 57 ALA B 65 1 9 HELIX 14 14 LYS B 74 LEU B 76 5 3 HELIX 15 15 GLY B 82 CYS B 84 5 3 HELIX 16 16 TYR B 89 HIS B 95 1 7 HELIX 17 17 PRO B 97 ASP B 106 1 10 HELIX 18 18 TYR B 118 ARG B 124 1 7 HELIX 19 19 GLU B 126 ARG B 134 1 9 HELIX 20 20 GLN B 144 PHE B 154 1 11 HELIX 21 21 SER B 159 TYR B 164 1 6 SHEET 1 A 6 GLY A 181 TYR A 188 0 SHEET 2 A 6 THR A 171 VAL A 178 -1 N VAL A 178 O GLY A 181 SHEET 3 A 6 ILE A 4 CYS A 7 -1 N LEU A 6 O LEU A 173 SHEET 4 A 6 VAL A 138 ILE A 141 1 N VAL A 138 O TYR A 5 SHEET 5 A 6 LYS A 50 SER A 54 1 N LYS A 50 O LEU A 139 SHEET 6 A 6 GLU A 71 TRP A 73 1 N GLU A 71 O THR A 53 SHEET 1 B 5 CYS B 182 TYR B 188 0 SHEET 2 B 5 THR B 171 PRO B 177 -1 N THR B 176 O ARG B 183 SHEET 3 B 5 ILE B 4 CYS B 7 -1 N LEU B 6 O LEU B 173 SHEET 4 B 5 VAL B 138 ILE B 141 1 N VAL B 138 O TYR B 5 SHEET 5 B 5 LYS B 50 TRP B 52 1 N LYS B 50 O LEU B 139 LINK C ARG A 8 N NEP A 9 1555 1555 1.32 LINK C NEP A 9 N GLY A 10 1555 1555 1.33 LINK C ARG B 8 N NEP B 9 1555 1555 1.33 LINK C NEP B 9 N GLY B 10 1555 1555 1.32 CRYST1 48.230 56.520 90.900 90.00 94.48 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020734 0.000000 0.001625 0.00000 SCALE2 0.000000 0.017693 0.000000 0.00000 SCALE3 0.000000 0.000000 0.011035 0.00000 MTRIX1 1 -0.999546 -0.029783 -0.004615 36.44650 1 MTRIX2 1 -0.028588 0.888466 0.458052 -10.40655 1 MTRIX3 1 -0.009541 0.457976 -0.888914 46.48539 1